Sun Pharma Tie-Up With NIV


On Tuesday sun pharma announced that they signed an agreement with NIV (National Institute of Virology), Pune for testing phytopharmaceutical, biological and chemical entities developed by the company against Zika dengue and Chikungunya Virsues. The NIV is an institution of the Department of Health Research, Indian Council of Medical Research and Ministry of Health and family Welfare.
NIV gets molecules from sun pharma for testing against Zika, Dengue and Chikunguniya in the model system. The data is taken as a commercial development. The tie-up aim is to promote discovery science, translation health research and development of medical products, which is in sync with the direction provided by government’s ‘Make In India’ initiative.

For conducting joint scientific research and innovation both the sun pharma and NIV follows its MoU with Indian Council of Medical Research (ICMR). They work together to respond to significant and emerging public health threats in India and the rest of the world due to viruses including Dengue, Zika and Chikungunya.

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔
Share on Google Plus

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: